Melius Research and Needham began covering Anthropic with buy ratings and price targets of $155 and $150, respectively, against its $83 IPO price ahead of its 19 November Nasdaq debut, CNA reported. Anthropic, the company behind Claude, is due to trade under the ticker ANT, CNBC reported.
Key points
- Melius set a 24-month target of $155, implying nearly 87% upside from the IPO price.
- Five brokerages’ targets range from $105 to $155.
- Melius and Citizens expect Anthropic’s revenue to exceed $400 billion by 2029.
Melius sets a 24-month target
Melius analyst Ben Reitzes set the $155 target over 24 months. Citizens began coverage with a market outperform rating and a $125 target. Wolfe Research assigned an outperform rating and a $135 target, while New Street Research gave Anthropic a buy rating and a $105 target.
Anthropic shares indicated above $83 IPO price
Anthropic shares were indicated to open at $105, or 26.5% above the IPO price, as of 10:45 am Eastern time on 19 November, CNA reported. Reuters reported an indicated opening around 32% above the IPO price.
Anthropic priced its Nasdaq IPO at $83 a share, above its preliminary range. The sale raised about $81 billion, exceeding SpaceX’s $75 billion IPO, CNN reported. A separate $26 billion investment from major technology companies brought Anthropic’s total proceeds to about $107 billion.
Anthropic’s computing commitments approach $900 billion
Anthropic has nearly $900 billion in computing commitments with partners including Amazon and Alphabet’s Google. CNN reported that the company is not yet profitable as it spends on computing power to train its models and serve users.
Melius Research and Citizens expect Anthropic’s revenue to exceed $400 billion by 2029, CNA reported.